<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Veterinary Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1CB4512E-B662-46F2-BFFD-915274941D56"><gtr:id>1CB4512E-B662-46F2-BFFD-915274941D56</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Franklin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/66A5BDB7-A64C-4D7B-9EEC-9F9CA13AD5C7"><gtr:id>66A5BDB7-A64C-4D7B-9EEC-9F9CA13AD5C7</gtr:id><gtr:firstName>Ragnhildur</gtr:firstName><gtr:otherNames>Thora</gtr:otherNames><gtr:surname>Karadottir</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701476"><gtr:id>4FCE8FB7-C449-4A34-9C50-AAA019BD1DC8</gtr:id><gtr:title>Neurotransmitter signalling to two types of oligodendrocyte precursor cell in remyelination</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701476</gtr:grantReference><gtr:abstractText>For nerve fibres in the brain and spinal cord (the central nervous system, or CNS) to work properly, and enable us to feel, move, talk, see, think etc., they need to be covered by a sheath called myelin. In many neurological diseases myelin is lost and nerve fibres cannot conduct impulses properly, and may even die. Just as a skin wound can heal, myelin injuries can be healed spontaneously by stem cells present in the CNS. However, this repair process, called remyelination, often fails. Scientists are therefore studying how CNS stem cells can be encouraged to heal myelin injury more efficiently. In this project we will determine the role of two distinct CNS stem cells that we have recently identified in remyelination.

When myelin is first produced in the developing brain the process is influenced by small molecules released from neurons, called neurotransmitters. However, it is unknown whether these neurotransmitters can influence remyelination. In this project we will study how remyelination by one or both types of stem cell is regulated by neurotransmitters. The results of this project will help in devising new remyelination therapies.</gtr:abstractText><gtr:technicalSummary>Demyelination has profound consequences for the efficiency of action potential conduction along axons, and for axonal integrity. In the CNS demyelination can be followed by a regenerative process called remyelination. However, in many myelin diseases (e.g. multiple sclerosis, trauma, stroke, cerebral palsy) remyelination is inadequate. Consequently, treatment of myelin diseases requires the development of remyelination-enhancing therapies, of which there are currently none. Remyelination is mediated by an endogenous population of stem/precursor cells called oligodendrocyte precursor cells (OPCs). We have recently shown that there are two populations of OPCs with distinct electrophysiological phenotypes: one type expresses voltage-gated sodium channels, fires action potentials and receives synaptic input, whereas the other type does not. At present it is not known whether both types of OPC become activated following demyelination and are able to differentiate into remyelinating oligodendrocytes. Furthermore, normal myelination has been shown to be influenced by axonal action potentials and neurotransmitter signalling, but at present there is no knowledge available regarding the effect of neurotransmitters on remyelination. This project will address the important questions of which OPC type should be targeted for remyelination-enhancing therapies, and whether modulation of neurotransmitter signalling could be used to enhance remyelination.</gtr:technicalSummary><gtr:fund><gtr:end>2012-05-09</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-05</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>480384</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Clinical Neurosciences</gtr:department><gtr:description>Electrical properties of neurons and oligodendrocytes derived from human embryonic stem cells</gtr:description><gtr:id>901F9CA5-BF16-4DF9-94CC-5D7BC724C958</gtr:id><gtr:impact>Outcome resulted from this collaboration the following publications;

Stacpoole SR, Bilican B, Webber DJ, Luzhynskaya A, He XL, Compston A, Karadottir R, Franklin RJ, Chandran S (2011). Efficient derivation of NPCs, spinal motor neurons and midbrain dopaminergic neurons from hESCs at 3% oxygen. Nat. Protoc. 6(8):1229

Stacpoole S.R., Bilican B., Webber, D.J., Luzhynskaya, A., He, X.L., Compston, A., Karadottir, R., Franklin, R.J., Chandran, S. (2011). Derivation of neural precursor cells from human ES cells at 3% O(2) is efficient, enhances survival and presents no barrier to regional specification and functional differentiation. Cell Death Differ. 6(18):1016- 23</gtr:impact><gtr:outcomeId>RZG4RrifLDN-1</gtr:outcomeId><gtr:partnerContribution>Provided us with the opportunity to study the electrical properties of human neuronal cells and most importantly, human oligodendrocyte precursor cells (OPCs), which is extremely important to assert which animal model currently available to study the properties of these cell best represents the human OPCs.</gtr:partnerContribution><gtr:piContribution>We both share scientific interest in neuronal stem cells. My laboratory has the experience on the electrical properties of neuronal cells, with the main focus on the electrical properties of oligodendrocytes. The laboratory of Professor Siddharthan Chandran at the Department of Clinical Neurosciences, University of Cambridge has expertise in human embryonic stem cells. Combining our knowledge has resulted in two publications (as listed below), furthermore we are currently expanding this work to address the electrical properties of human oligodendrocytes.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Physics of Medicine</gtr:department><gtr:description>Mechanical properties of CNS tissue in health and disease</gtr:description><gtr:id>FF2B2B54-4370-46BE-B455-43B2390AB014</gtr:id><gtr:impact>Outcome resulted from this collaboration the following publication:
Christ AF, Franze K, Gautier H, Moshayedi P, Fawcett J, Franklin RJM, Karadottir RT, Guck J. Mechanical difference between white and gray matter in the rat cerebellum measured by scanning force microscopy. J Biomech. 2010 16;43(15):2986-92. PMID: 20656292 [PubMed - in process]
This is a multi- disciplinary approach as we combine cell physiology with atom force microscopy. Therefore the disciplines are cell physilogy and physics</gtr:impact><gtr:outcomeId>WxL7JUqfNu1-1</gtr:outcomeId><gtr:partnerContribution>We are both interested in myelin repair and the concept of a difference in tissue mechanics in health and disease is a new idea to us. As currently we focus on biological factors of repair; however mechanical factors also play a role. Thus this collaboration has widened our horizon and possible approach to study white matter disease.
 We have recently published a paper together in J. Biomech. 2010 titled &amp;quot;Mechanical difference between white and gray matter in the rat cerebellum measured by scanning force microscopy&amp;quot;. Which demonstrates: 1. it is possible to measure the CNS mechanical differences 2. That there are measurable differences between different layers of the brain and 3 we can measure at high enough resolution to measure mechanical properties in white matter lesions. This was the background of a new PhD project &amp;quot; a nanoscience approach to mechanosensing in the central nervous system&amp;quot; - jointly supervised.</gtr:partnerContribution><gtr:piContribution>As mentioned above, we both share scientific interest in white matter disease. We have set up multi-disciplinary approach to study remyelination. My laboratory has the experience to work with white matter, CNS tissue, animals and the knowledge of the biological properties of the white matter and repair. The laboratory of Jochen Guck at The Cambridge Centre for the Physics of Medicine has the knowledge of atom force microscope and measurements of tissue mechanics. Combining our knowledge has resulted in a publication of the difference mechanical properties of white and grey matter in the rat cerebellum (J. Biomech. 2010), which now forms the bases of a PhD project which started in 2010.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Imperial College Trust</gtr:department><gtr:description>Neuronal activity regulates remyelination via glutamate signaling to oligodendrocyte progenitors</gtr:description><gtr:id>F11C02BF-FD9B-4145-8FFD-CFCF7F2136D5</gtr:id><gtr:impact>Gautier HO, Evans K, Lundgaard I, James F, Lao-Peregrin C, Franklin RJM &amp;amp; K&amp;aacute;rad&amp;oacute;ttir R (2015). Neuronal activity regulates remyelination via glutamate signaling to oligodendrocyte progenitors. Nature Communications 6: 8518</gtr:impact><gtr:outcomeId>56ddaa2865ab08.33982432-1</gtr:outcomeId><gtr:partnerContribution>Prof. Richard Reynolds laboratory supplied MS tissue samples and performed immunohistology and confocal imaging of these samples for the manuscript relating to the effect of neuronal activity in remyelination</gtr:partnerContribution><gtr:piContribution>We had made a discovery that OPCs receives synaptic inputs from demyelinated axons, and this synaptic communication is essential for remyelination. We identified proteins that we can look at in the lesions, and these proteins were investigated in Prof. Richard Reynolds laboratory. We preformed analysis of the images Richard's lab sent us. This led to a submission of a paper in Gautier et al., Nat. Communications 2015.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Stem Cell Institute</gtr:department><gtr:description>Wellcome Trust - MRC Cambridge Stem Cell Institute</gtr:description><gtr:id>27BF899A-E19B-4F05-8D93-24AC60B48E12</gtr:id><gtr:impact>Outcome resulted from this collaboration the following publications;

Stacpoole SR, Bilican B, Webber DJ, Luzhynskaya A, He XL, Compston A, Karadottir R, Franklin RJM, Chandran S (2011). Efficient derivation of NPCs, spinal motor neurons and midbrain dopaminergic neurons from hESCs at 3% oxygen. Nat. Protoc. 6(8):1229

Stacpoole S.R., Bilican B., Webber, D.J., Luzhynskaya, A., He, X.L., Compston, A., Karadottir, R., Franklin, R.J.M., Chandran, S. (2011). Derivation of neural precursor cells from human ES cells at 3% O(2) is efficient, enhances survival and presents no barrier to regional specification and functional differentiation. Cell Death Differ. 6(18):1016- 23</gtr:impact><gtr:outcomeId>m2z8kR2JqtE-1</gtr:outcomeId><gtr:partnerContribution>Being part of the WT-MRC Cambridge Stem Cell Institute, has been an excellent platform to interact with other investigators interested in stem cell biology and given me access to MRC and Wellcome Trust funded PhD students selected on the 4 year PhD programme in Stem Cell Biology, organised by the initiative. Furthermore, a successful collaboration with Professor Siddharthan Chandran, that resulted in two publication (listed below) came about through our interaction in events organised by the initiative.</gtr:partnerContribution><gtr:piContribution>My laboratory provides both training and collaboration on isolation of neuronal stem cell from the brain, patch-clamp recordings (in both cell culture and brain slices), imaging (calcium, time-lapse and confocal).</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cambridge MS research day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>83153C7D-8012-4F86-A476-27CAF4F36031</gtr:id><gtr:impact>Around 100 MS patients, physiotherapists and nurses attendend this meeting where scientist working on MS reserach present their newest work for lay audience

Audience suffering from MS congratulated us on our work and for making &amp;quot;complicated&amp;quot; science accessible. In general the audience was very complimentary to our presentations.</gtr:impact><gtr:outcomeId>DHW9ZjBrabc</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kastljos - RUV  -Icelandic national television service RUV</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>986BE597-B229-493F-BDD5-659D97151CEF</gtr:id><gtr:impact>TV interview for a news specialist program - similar to Newsnight - but for the national television in Iceland</gtr:impact><gtr:outcomeId>56ddb2c6040a78.33209703</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Icelandic national television service RUV</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CA9F1AA1-601F-482C-AFE2-0398AF21F6C0</gtr:id><gtr:impact>Icelandic national television service RUV News interview</gtr:impact><gtr:outcomeId>56ddb41a528101.46194376</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>public lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0E4DB155-79B2-4B82-B47F-8947746D2A12</gtr:id><gtr:impact>ERA-Net NEURON II Foresight symposium due to the european month of the brain - this was the public lecture open to all member of the public. Those that attended where scientists from various background, policy makers, politicians and the general public

Number of emails after the talk from the general audience about my work and white matter disease and I was invited for a radio interview.</gtr:impact><gtr:outcomeId>pfeZAGWJsni</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.neuron-eranet.eu/_media/Symposium_Reykjavik_2013.pdf</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National radio Ras2</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D2BB9FE5-082A-4412-8CFD-8AA75781E61D</gtr:id><gtr:impact>National radio Ras2 interview</gtr:impact><gtr:outcomeId>56ddb45d580ea7.91953897</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3A6CCEDA-BBE2-482A-89F8-C230B2FA685F</gtr:id><gtr:impact>University of Cambridge made a press release on our paper (Gautier et al., Nat. Communications 2015), this press release was taken up by other press releases and talked - highlighted on number of international science media web pages</gtr:impact><gtr:outcomeId>56ddb8ede27513.49326087</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cam.ac.uk/research/news/calling-for-help-damaged-nerve-cells-communicate-with-stem-cells</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk for Action Medical Research charity lunch meeting in Peterborough</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>30BF5C28-64B8-4B0C-A54F-CA37FFC95A20</gtr:id><gtr:impact>around 50 people attented the lunch where I held my presentation, which evoked long discussions into medical research and white matter disease in particular. Followed by me reciving few emails afterwards from members in the audience.

Around 50 people attended the lunch where I held my presentation, which evoked long discussions into medical research and white matter disease in particular. After the event I received some emails afterwards from members in the audience, commenting and asking questions regarding the talk.</gtr:impact><gtr:outcomeId>RAgNYmYN5ez</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival - Stem cells: unravelling brain disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EA5C8505-19ED-4FB6-AF09-8B0B1900D1C6</gtr:id><gtr:impact>Cambridge Science Festival - Stem cells: unravelling brain disease - a public talk,</gtr:impact><gtr:outcomeId>56ddb48dd936c5.77313234</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Action Medical Research Charity meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9B5F76AA-6A06-4575-9C9E-82E0B91103FF</gtr:id><gtr:impact>Around 50 persons attended this meeting which was to inform fundraising volunteers for Action Medical Research about the type of research the charity funds. My presentation was shown great interest demonstrated by multiple questions and discussions afterwards that further continued with individual participants

I was requested to come and speak at AMR fundraising event.</gtr:impact><gtr:outcomeId>czqNTJkQwsg</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Neuroscience Association news magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9D64B882-DFB3-44DC-80D8-A01F546D9E92</gtr:id><gtr:impact>Interview for the quarterly British Neuroscience Association news magazine</gtr:impact><gtr:outcomeId>56ddb323d89777.34188454</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge - TV</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5EC604E4-4AC4-4F1E-8DCA-CF65543D9ACA</gtr:id><gtr:impact>Cambridge TV interview</gtr:impact><gtr:outcomeId>56ddb35760e929.63659942</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>26067F21-BD21-4943-9E78-1D2E382A97E7</gtr:id><gtr:impact>Radio interview at the Icelandic National Radio station, so the target audience was the general public

Was invited to give lecture to Neurologists in Iceland</gtr:impact><gtr:outcomeId>EjMigrDnXb9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>Pre-2006,2006,2008,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Icelandic national news paper - Morgunbladid</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A1907C85-3B91-4189-A84B-DAA07DFE6905</gtr:id><gtr:impact>This was national new paper interview - Icelandic interview for Morgunbladid</gtr:impact><gtr:outcomeId>56ddb27458c378.79730847</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Women in Science</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D8456BC4-6E7A-4A5E-AFBB-2F55CFB8DF68</gtr:id><gtr:impact>This event was organaised by The Norwegian Academy of Science and Letters and the title was &amp;quot;Bridging science and carriere development: Women in frontline science - what is their experience?&amp;quot; 10-11 November 2011 .

I was invited as a speaker to speak about my research and personal drive to juggle science and familiy. The title of my talk was &amp;quot;Oligedendrocyte: The most vulnerable cell in the brain. &amp;quot;

After my talk I spoke with a number of postdocs and PhD students. In addition, I formed a collaboration with Kristine Walhovd and I was offered 10% professorship at the Univeristy of Oslo.</gtr:impact><gtr:outcomeId>Zg56sp1R1PK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E97B5784-0331-45E7-9606-E86CD95B8460</gtr:id><gtr:impact>The event took place at St Catharine's College, Cambridge, 
30 students from years 10 and 11 attendant the event, and the students seem to enjoy the presentation


none</gtr:impact><gtr:outcomeId>VXaTzJc4WEb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>13240</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Equipment grant RG2010R1 (The role of NRG, voltage-gated sodium channels and intracellular signalling in myelination)</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:fundingRef> RG2010R1</gtr:fundingRef><gtr:id>DC79C79A-34C9-4BEF-AF5F-997F7FD63A7C</gtr:id><gtr:outcomeId>hffbEc4pWAM0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lister Institute research prize</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Lister Institute of Preventive Medicine</gtr:fundingOrg><gtr:id>662C8DF9-7938-4309-8E55-7D2DB793156D</gtr:id><gtr:outcomeId>56ddad2b1f95c5.93188045</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>932296</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Research Career Development Fellowship in Basic Biomedical Science; 091543 (Determinants of oligodendrocyte cell fate in development and disease)</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>091543/Z/10/Z</gtr:fundingRef><gtr:id>DC8AD981-DB37-48AC-A156-1A32C842E0E6</gtr:id><gtr:outcomeId>A5oEbZX8XmX0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>It is a platform of blue LED lights that have heat removing block on top. They are build in a circuit and connected to a power source that controls the intensity of light, duration and frequency, further connected to a timer that allows for 12hrs cycles. This box allows for light activation of cells in culture. This box is useful when studying light activation of proteins and photo toxicity in culture, as it is suitable for being inside an incubator. This was done in collaboration with the electrical workshop in the University of Cambridge.</gtr:description><gtr:id>4449CA48-463E-4BEC-8B56-E814A94AA290</gtr:id><gtr:impact>Other groups have asked for the drawings of this box and how to build it. We have supplied it to reaserach groups in USA.</gtr:impact><gtr:outcomeId>a6CKEAoioHn</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Light activating box - sutiable for an incubator</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7D3BC2AC-8E07-41F1-A68C-F3F8740EB22D</gtr:id><gtr:title>The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f1e48873a7d1502eb6dc990934eb3f3"><gtr:id>0f1e48873a7d1502eb6dc990934eb3f3</gtr:id><gtr:otherNames>Kolodziejczyk K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>6A6175D067F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4E664C3-D9E0-4F45-984A-294FC474494D</gtr:id><gtr:title>Efficient derivation of NPCs, spinal motor neurons and midbrain dopaminergic neurons from hESCs at 3% oxygen.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f045bf196326e3cba2157dc8deb0fa7"><gtr:id>0f045bf196326e3cba2157dc8deb0fa7</gtr:id><gtr:otherNames>Stacpoole SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>K3R3ELBMbEA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34BCF1D2-D199-4EBA-8BCE-EEE482CDB13F</gtr:id><gtr:title>Deconstructing myelination: it all comes down to size.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13e9c90b8685b080088a306389dd96be"><gtr:id>13e9c90b8685b080088a306389dd96be</gtr:id><gtr:otherNames>K?rad?ttir RT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>pm_13127_27_22936168</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10358ACE-0EFE-4346-BCB2-B0AC32ADC162</gtr:id><gtr:title>Electrical signalling properties of oligodendrocyte precursor cells.</gtr:title><gtr:parentPublicationTitle>Neuron glia biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d65487e56b27b5c3db363045fc4296e"><gtr:id>8d65487e56b27b5c3db363045fc4296e</gtr:id><gtr:otherNames>Bakiri Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1740-925X</gtr:issn><gtr:outcomeId>E65867D2DB4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46A8C20B-51B3-4FC1-B58F-21C2042E460E</gtr:id><gtr:title>Niche derived oligodendrocyte progenitors: a source of rejuvenation or complementation for local oligodendrogenesis?</gtr:title><gtr:parentPublicationTitle>Frontiers in cellular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c44ec2897feb8777755b6fb56d603d85"><gtr:id>c44ec2897feb8777755b6fb56d603d85</gtr:id><gtr:otherNames>Agathou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1662-5102</gtr:issn><gtr:outcomeId>pm_13127_27_24155691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>191A080D-AF56-4110-8571-8A2AAFDF0DDD</gtr:id><gtr:title>Glutamatergic signaling in the brain's white matter.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d65487e56b27b5c3db363045fc4296e"><gtr:id>8d65487e56b27b5c3db363045fc4296e</gtr:id><gtr:otherNames>Bakiri Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>D0AD3919129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C40A3650-0484-4FAF-BB93-E2AFB744A4A3</gtr:id><gtr:title>Brain tissue stiffness is a sensitive marker for acidosis.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0760de6b301c773c6216700b62794c04"><gtr:id>0760de6b301c773c6216700b62794c04</gtr:id><gtr:otherNames>Holtzmann K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>585d3489861cf6.94175754</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36191736-0281-437F-85C3-067A71098270</gtr:id><gtr:title>Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d78f3a124bc32f0a68ac93e02631be1b"><gtr:id>d78f3a124bc32f0a68ac93e02631be1b</gtr:id><gtr:otherNames>Lundgaard I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>pm_540e159e15949eef1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3D71697-17D0-4073-B749-95C56E5E1CE9</gtr:id><gtr:title>Derivation of neural precursor cells from human ES cells at 3% O(2) is efficient, enhances survival and presents no barrier to regional specification and functional differentiation.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f045bf196326e3cba2157dc8deb0fa7"><gtr:id>0f045bf196326e3cba2157dc8deb0fa7</gtr:id><gtr:otherNames>Stacpoole SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>CUVxrKNatjc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24FC6A61-DEB5-44DF-B3A3-23198BB2B9B3</gtr:id><gtr:title>Clever glia.</gtr:title><gtr:parentPublicationTitle>Stem cell research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/324a2d66d4720c42aa4f76127f3536b4"><gtr:id>324a2d66d4720c42aa4f76127f3536b4</gtr:id><gtr:otherNames>Spitzer S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1757-6512</gtr:issn><gtr:outcomeId>pm_13127_27_23998426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>044C9E2C-7F82-4A10-8415-45D0BEAC2B91</gtr:id><gtr:title>Mechanical difference between white and gray matter in the rat cerebellum measured by scanning force microscopy.</gtr:title><gtr:parentPublicationTitle>Journal of biomechanics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1296ce83c98259a4bc322261ead794d5"><gtr:id>1296ce83c98259a4bc322261ead794d5</gtr:id><gtr:otherNames>Christ AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9290</gtr:issn><gtr:outcomeId>MHryBngb5CB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F76CAB7-E0C7-4994-9F49-0E09C8A2C489</gtr:id><gtr:title>Morphological and electrical properties of oligodendrocytes in the white matter of the corpus callosum and cerebellum.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d65487e56b27b5c3db363045fc4296e"><gtr:id>8d65487e56b27b5c3db363045fc4296e</gtr:id><gtr:otherNames>Bakiri Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>bwPLszHDd4h</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9AB93EC-7B4F-4200-B4C8-CF0225F6BBB0</gtr:id><gtr:title>Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3aa41922c2bf211c0893bdb7c3b2ddd"><gtr:id>f3aa41922c2bf211c0893bdb7c3b2ddd</gtr:id><gtr:otherNames>Gautier HO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56d826b8462b20.77209113</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701476</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>